FORT MYERS, Fla., Oct. 22, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute (FCS) leaders will be among the featured presenters as executive stakeholders from across the U.S.

Oral Presentation to be Featured on Initial Results of a First-in-Human Study for a Promising Targeted Therapy for Advanced/Metastatic Solid Tumors. ESMO 2025 abstracts featuring FCS research: 965P, ...

McKesson's acquisition of FCS' Core Ventures integrates FCS into The US Oncology Network, expanding its reach to over 700 locations and 1.5 million patients annually. The consolidation trend in ...

LAKE WALES, Fla. (WFLA) — The Florida Cancer Specialists & Research Institute is informing cancer patients it is closing its Lake Wales office, effective Jan. 29, 2025. “I just think it’s very unfair, ...

The $2.49 billion cash purchase will give McKesson about 70% ownership of Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). The $2.49 billion cash purchase will give McKesson ...

Acquisition enhances McKesson’s integrated oncology platform; Florida Cancer Specialists & Research Institute to join The US Oncology Network It’s an unprecedented time for patients living with cancer ...

McKesson has signed a definitive agreement for a $2.5 billion controlling stake in a subsidiary of Florida Cancer Specialists & Research Institute, a physician-owned oncology clinic operator. McKesson ...

FORT MYERS, Fla., May 16, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) this week celebrated the opening of its newest patient care facility—the largest of the nearly ...

Fort Myers-based Florida Cancer Specialists & Research Institute has selected Michael Diaz, MD, as president and managing physician, effective Jan. 1, 2022. In addition to his new role, Dr. Diaz will ...

McKesson has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures (Core Ventures). Core Ventures, a business and administrative ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise ...